Why the study?
Does pretreatment with AT1 receptor antagonists protect against neuronal injury induced by oxygen-glucose depletion in rat neuron-astrocyte cultures?
Population
Primary rat neuron-astrocyte co-cultures, astrocyte-defined medium-cultured pure astrocyte cultures, and…
Comparison
Pretreatment with AT1 receptor antagonists for… vs No AT1 receptor antagonist pretreatment
Design
Preclinical
Follow-up
48 h (pretreatment duration)
Key result
Pretreatment with AT1 receptor antagonists attenuated oxygen-glucose depletion-induced cellular damage and enhanced GLT-1 expression and glutamate uptake activity in rat neuron-astrocyte co-cultures.
Authors
Loading...
May support neuroprotection research with AT1 antagonists; leaves open translation to clinical ischaemic stroke therapy.
Does pretreatment with AT1 receptor antagonists protect against neuronal injury induced by oxygen-glucose depletion in rat neuron-astrocyte cultures?
AT1 receptor antagonists protect against ischaemic neuronal injury in vitro by up-regulating GLT-1 expression and enhancing glutamate uptake.
Wu et al. (2010) studied Ischaemic injury. AT1 receptor antagonists (losartan or telmisartan) vs. Control (no antagonist or AT1 receptor agonists) was evaluated on Cellular damage (lactate dehydrogenase release) and GLT-1 expression/activity. Pretreatment with AT1 receptor antagonists attenuated oxygen-glucose depletion-induced cellular damage and enhanced GLT-1 expression and glutamate uptake activity in rat neuron-astrocyte co-cultures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: